Last Verified: | March/31/2019 |
First Submitted: | December/13/2018 |
Estimated Enrollment Submitted: | December/17/2018 |
First Posted: | December/20/2018 |
Last Update Submitted: | April/1/2019 |
Last Update Posted: | April/2/2019 |
Actual Study Start Date: | December/19/2018 |
Estimated Primary Completion Date: | February/6/2019 |
Estimated Study Completion Date: | February/9/2019 |
Study Type: | Interventional |
Allocation: | Randomized |
: | Prospective, Randomized, Placebo-Controlled Clinical Trial |
Primary Purpose: | Treatment |
Masking: | Single (Participant) |
: | Single (Participant) |
Arm | Intervention/treatment |
---|---|
Placebo Comparator: placebo 250 ml saline will be administered 60 minutes before the onset of Electroconvulsive therapy procedure. Electroconvulsive therapy (ECT) is one of the effective and life-saving treatment modality used in psychiatry for a long time because it responds more rapidly than pharmacological treatment. | Drug: placebo 250 ml saline will be administered 60 minutes before the onset of Electroconvulsive therapy procedure. All administrations will be applied through IV infusion over 60 minutes. |
Active Comparator: paracetamol 1 g paracetamol will be administered 60 minutes before the onset of Electroconvulsive therapy procedure. Electroconvulsive therapy (ECT) is one of the effective and life-saving treatment modality used in psychiatry for a long time because it responds more rapidly than pharmacological treatment. | Drug: paracetamol 1 g paracetamol will be administered 60 minutes before the onset of Electroconvulsive therapy procedure. All administrations will be applied through IV infusion over 60 minutes. |
Active Comparator: ibuprofen 800 mg ibuprofen will be administered 60 minutes before the onset of Electroconvulsive therapy procedure. Electroconvulsive therapy (ECT) is one of the effective and life-saving treatment modality used in psychiatry for a long time because it responds more rapidly than pharmacological treatment. | Drug: ibuprofen 800 mg ibuprofen will be administered 60 minutes before the onset of Electroconvulsive therapy procedure. All administrations will be applied through IV infusion over 60 minutes. |
Ages Eligible for Study: | 18 Years to 18 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Criteria: | Inclusion Criteria: - Patients with major depression - Patients with American Society of Anesthesiologists (ASA) scores I or II - Between 18-65 Exclusion Criteria: - Patients with ASA scores III/IV, - Under the age of 18, - Over the age of 65, - Myocardial infarction, - Congestive heart failure, - Pulmonary disease, - Stroke history, - Bleeding disorder, - Hepatic and renal dysfunction, - Pregnant, - Migraine history, - Allergy of nonsteroidal anti-inflammatory drugs, paracetamol, propofol, - Neuromuscular disease, - Peptic ulcer disease, - Intracranial hypertension, - Glaucoma - Patients who did not give informed consent |